Dentons advises on Advanced Oncotherapy's £20 million fundraising
Dentons has advised Westhouse Securities and Beaufort Securities as joint brokers on a £20 million fundraising for Advanced Oncotherapy.
Advanced Oncotherapy develops next generation proton therapy systems for cancer treatment. Its fundraising will continue the development of its LIGHT (Linac for Image Guided Hadron Therapy) systems with the first unit expected to be installed in Harley Street, London, by the end of 2016. Patients are expected to begin treatment in 2017.